Physician
Shore Fun Pediatrics
Shore Fun Pediatrics was paid $2.45M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoSHORE FUN PEDIATRICS
SUPPLY, NC 28462
SUPPLY, NC 28462
33aNPI1750420428assigned 02/06/2007
33bProvider typePediatrics Physician
28Total paid$2.45M
24GClaims184,200
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in North Carolina
Rank by total paid#140 of 433
Median peer was paid$942K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,721 | $289K | |
| 2019 | 12,790 | $359K | |
| 2020 | 10,332 | $282K | |
| 2021 | 17,755 | $298K | |
| 2022 | 37,841 | $382K | |
| 2023 | 44,278 | $404K | |
| 2024incomplete | 51,483 | $441K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 11,462 | 9,770 | $873K |
| 99199 | Unlisted special service, procedure or report | 22% | 109,360 | 52,509 | $541K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 8,492 | 7,192 | $442K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.5% | 4,761 | 4,151 | $85K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.4% | 964 | 794 | $83K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.2% | 2,536 | 2,174 | $80K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.0% | 973 | 828 | $73K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.9% | 878 | 767 | $72K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.6% | 542 | 459 | $40K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 2,528 | 2,203 | $26K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.0% | 349 | 290 | $25K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 856 | 638 | $23K |
44 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 654 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 347 | $15K |
| 96127 | <1% | 2,898 | $11K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,532 | $11K |
| 96160 | <1% | 3,340 | $10K | |
| 92551 | <1% | 4,936 | $5K | |
| 81002 | <1% | 5,092 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,431 | $3K |
| 99173 | <1% | 5,266 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 129 | $2K |
| 90474 | <1% | 107 | $2K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 55 | $2K |
| 80061 | Lipid panel | <1% | 118 | $1K |
| 81003 | <1% | 640 | $1K | |
| 90651 | <1% | 75 | $1K | |
| 90473 | <1% | 88 | $1K | |
| 90461 | <1% | 167 | $855.12 | |
| 90686 | <1% | 1,300 | $844.05 | |
| D1206 | Topical application of fluoride varnish | <1% | 58 | $771.41 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 49 | $633.42 |
| 85018 | <1% | 622 | $560.12 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 49 | $509.00 |
| 69210 | <1% | 14 | $431.04 | |
| 90734 | <1% | 17 | $401.70 | |
| 85013 | <1% | 25 | $73.00 | |
| 90672 | <1% | 132 | $23.64 | |
| 94760 | <1% | 491 | $12.42 | |
| 36416 | 0% | 159 | $0.00 | |
| 3074F | 0% | 1,069 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 52 | $0.00 |
| 3008F | 0% | 1,106 | $0.00 | |
| 2001F | 0% | 1,628 | $0.00 | |
| 90697 | 0% | 12 | $0.00 | |
| 90647 | 0% | 20 | $0.00 | |
| 90680 | 0% | 13 | $0.00 | |
| 90656 | 0% | 13 | $0.00 | |
| 3078F | 0% | 1,043 | $0.00 | |
| 1160F | 0% | 4,454 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 1,073 | $0.00 |
| 90710 | 0% | 13 | $0.00 | |
| 90670 | 0% | 140 | $0.00 | |
| 90658 | 0% | 32 | $0.00 | |
| 90633 | 0% | 12 | $0.00 | |
| 90671 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPIVEY-COCHRAN, BRUCIE (PRACTICE MANAGER)